AMICUS THERAPEUTICS INC 4
4 · AMICUS THERAPEUTICS INC · Filed Jul 15, 2015
Insider Transaction Report
Form 4
Valenzano Ken
VP, Pharmacology & Biology
Transactions
- Exercise/Conversion
Common stock
2015-07-13$15.00/sh+3,000$45,000→ 30,687 total - Sale
Common stock
2015-07-13$15.00/sh−3,000$45,000→ 27,687 total - Exercise/Conversion
Stock Options (right to buy)
2015-07-13−9,500→ 0 totalExercise: $5.33From: 2010-02-01Exp: 2016-02-28→ Common Stock (9,500 underlying) - Sale
Common stock
2015-07-13$15.00/sh−2,500$37,500→ 27,687 total - Exercise/Conversion
Stock Options (right to buy)
2015-07-13−3,000→ 24,000 totalExercise: $4.38From: 2016-06-01Exp: 2022-06-04→ Common Stock (3,000 underlying) - Sale
Common stock
2015-07-13$15.00/sh−9,500$142,500→ 27,687 total - Exercise/Conversion
Common stock
2015-07-13$15.00/sh+2,500$37,500→ 30,187 total - Exercise/Conversion
Common stock
2015-07-13$15.00/sh+9,500$142,500→ 37,187 total - Exercise/Conversion
Stock Options (right to buy)
2015-07-13−2,500→ 20,000 totalExercise: $4.16From: 2013-11-01Exp: 2019-11-16→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2015.